Prevention of COVID-19 disease
Showing 26 - 50 of >10,000
COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel
Active, not recruiting
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
-
Yancheng, Jiangsu, ChinaFuning Center for Disease Control and Prevention
Oct 28, 2022
COVID-19, SARS-CoV-2 Pneumonia Trial in Huai'an (Recombinant COVID-19 vaccine (Sf9 cell))
Not yet recruiting
- COVID-19
- SARS-CoV-2 Pneumonia
- Recombinant COVID-19 vaccine (Sf9 cell)
-
Huai'an, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 19, 2022
SARS CoV-2 Virus Secretions and Serum for Countermeasure
Recruiting
- Covid19
-
New Orleans, Louisiana
- +1 more
Jul 19, 2022
Genomics and COVID-19 Vaccine Adverse Events
Recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccines
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital Research Institute
Jun 24, 2022
Safety, Immunogenicity, Vaccine, COVID-19 Vaccines Trial in Beijing (Vaccine)
Recruiting
- Safety
- +4 more
- Vaccine
-
Beijing, China
- +2 more
Mar 24, 2022
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 10, 2022
COVID-19 Trial in Yancheng (COVID-19 Vaccine,Inactivated)
Active, not recruiting
- COVID-19
- COVID-19 Vaccine,Inactivated
-
Yancheng, Jiangsu, ChinaSheyang County Center for Disease Control and Prevention
Apr 25, 2022
COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)
Recruiting
- COVID-19
- Inactivated COVID-19 Vaccine
-
Weihai, Shandong, ChinaRushan City Center for Disease Control and Prevention
Jan 19, 2022
Physiological Stress, Psychological Distress, COVID-19 Stress Syndrome Trial (Physical Activity Training, Mindfulness-based
Not yet recruiting
- Physiological Stress
- +2 more
- Physical Activity Training
- +2 more
- (no location specified)
Jul 31, 2022
Acute Respiratory Distress Syndrome, Coronavirus Infection Trial in Houston (vadadustat, )
Active, not recruiting
- Acute Respiratory Distress Syndrome
- Coronavirus Infection
- vadadustat
- placebo
-
Houston, TexasThe University of Texas Health Science Center at Houston
Mar 10, 2022
Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Trial
Recruiting
- Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
- Recombinant adenovirus type-5-vectored COVID-19 vaccine
-
Hangzhou, Zhejiang, ChinaXihu District Center for Disease Control and Prevention
May 12, 2022
COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO
Active, not recruiting
- COVID-19
- low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
- +2 more
-
Shang Qiu, He Nan, ChinaNing ling Center for Disease Control and Prevention
Jan 31, 2023
COVID-19, Vaccine Hesitancy Trial in Seattle (Vaccine Norms Feedback, Alcohol Norms Feedback)
Recruiting
- COVID-19
- Vaccine Hesitancy
- Vaccine Norms Feedback
- Alcohol Norms Feedback
-
Seattle, WashingtonUniversity of Washington
Mar 14, 2023
COVID-19 Trial in Beijing, Langfang, Changsha (COVID-19 mRNA vaccine, Placebo)
Recruiting
- COVID-19
- COVID-19 mRNA vaccine
- Placebo
-
Beijing, Beijing, China
- +2 more
Jul 8, 2022
COVID-19 Trial in Beijing, Langfang, Changsha (COVID-19 mRNA vaccine, Placebo)
Recruiting
- COVID-19
- COVID-19 mRNA vaccine
- Placebo
-
Beijing, Beijing, China
- +2 more
Jul 4, 2022
Safety of Pediatric COVID-19 Vaccination
Recruiting
- Pain
- +2 more
- Observational
-
Oakland, California
- +4 more
Jun 27, 2022
Covid19 Trial in Xinxiang (3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated, 3-doses schedule 2 of COVID-19
Recruiting
- Covid19
- 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
- +3 more
-
Xinxiang, Henan, ChinaYanjin County Center for Disease Control and Prevention
Jun 15, 2022
Developement of Infectious Airborne Disease Prevention Workplace Curriclulm Trial in Collingswood, Philadelphia (SAFE Employment
Recruiting
- Developement of Infectious Airborne Disease Prevention Workplace Curriclulm
- SAFE Employment Training
-
Collingswood, New Jersey
- +1 more
Oct 26, 2023
Cardiac Rehabilitation and Ongoing Physical Activity During
Completed
- Cardiac Rehabilitation
- No intervention
-
Salzburg, AustriaInstitute of Sports Medicine, Prevention and Rehabilitation
Dec 15, 2021
Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)
Completed
- Covid19
- SARS-CoV Infection
-
Johannesburg, Gauteng, South Africa
- +1 more
Jun 6, 2022
COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))
Completed
- COVID-19
- Recombinant Novel Coronavirus vaccine (CHO Cells)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 6, 2023
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial (Hydroxychloroquine, Vitamins and Minerals, Azithromycin)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Hydroxychloroquine
- +2 more
- (no location specified)
Dec 5, 2021
Observational Maternal COVID-19 Vaccination Study
Recruiting
- Pregnancy
- Observational
-
Atlanta, Georgia
- +3 more
Mar 22, 2022
COVID-19 Pneumonia Trial in Shang Qiu (Experimental Vaccine 1, Experimental Vaccine 2, Experimental Vaccine 3)
Active, not recruiting
- COVID-19 Pneumonia
- Experimental Vaccine 1
- +3 more
-
Shang Qiu, He Nan, ChinaNing ling Center for Disease Control and Prevention
Jul 20, 2022